These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23512791)

  • 1. Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.
    Salem R; Mazzaferro V; Sangro B
    Hepatology; 2013 Dec; 58(6):2188-97. PubMed ID: 23512791
    [No Abstract]   [Full Text] [Related]  

  • 2. Trans-Arterial Radioembolization for Hepatocellular Carcinoma.
    Sacco R; Giorgi L; Fornaro L; Bargellini I
    Dig Dis; 2015 Sep; 33(5):661-7. PubMed ID: 26398498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial Radioembolization (TARE) Agents beyond
    Bouvry C; Palard X; Edeline J; Ardisson V; Loyer P; Garin E; Lepareur N
    Biomed Res Int; 2018; 2018():1435302. PubMed ID: 30687734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
    Hickey RM; Lewandowski RJ; Salem R
    Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
    Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS
    J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablative Radioembolization of a Synchronous Renal Cell Carcinoma and Hepatocellular Carcinoma.
    McGregor H; Laidlaw G; Johnson G
    J Vasc Interv Radiol; 2023 Oct; 34(10):1847-1849. PubMed ID: 37391075
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives for yttrium-90 radioembolization as therapeutic option for hepatocellular carcinoma.
    Burrel M; Bermúdez P; Forner González A
    Rev Esp Enferm Dig; 2022 Apr; 114(4):195-197. PubMed ID: 35315679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for hepatocellular carcinoma after yttrium therapy: a case report.
    Sotiropoulos GC; Hilgard P; Antoch G; Nowak KM; Ertl J; Fouzas I; Molmenti EP; Sgourakis G; Beckebaum S; Paul A; Broelsch CE; Lang H
    Transplant Proc; 2008 Dec; 40(10):3804-5. PubMed ID: 19100496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial Radioembolization for Hepatocellular Carcinoma and Hepatic Metastases: Clinical Aspects and Dosimetry Models.
    Mikell JK; Dewaraja YK; Owen D
    Semin Radiat Oncol; 2020 Jan; 30(1):68-76. PubMed ID: 31727302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.
    Ahmed AF; Samreen N; Grajo JR; Zendejas I; Sistrom CL; Collinsworth A; Esnakula A; Shah JL; Cabrera R; Geller BS; Toskich BB
    Abdom Radiol (NY); 2018 Jul; 43(7):1825-1836. PubMed ID: 29052747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
    Toskich BB; Liu DM
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.
    Denys A; Pracht M; Duran R; Guiu B; Adib S; Boubaker A; Bize P
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):794-805. PubMed ID: 25828724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatopulmonary shunt reduction using chemoembolization to permit yttrium-90 radioembolization.
    Rose SC; Hoh CK
    J Vasc Interv Radiol; 2009 Jun; 20(6):849-51. PubMed ID: 19465310
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of radioembolization in identifying patients with favorable tumor biology before living donor liver transplantation.
    Yu YD; Kim DS; Jung SW; Kim Y; Suh SO
    Transplantation; 2014 Sep; 98(5):e47-50. PubMed ID: 25171535
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatocellular Carcinoma Tumor Dose Response After
    Kappadath SC; Mikell J; Balagopal A; Baladandayuthapani V; Kaseb A; Mahvash A
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):451-461. PubMed ID: 30191875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superselective yttrium-90 radioembolization for hepatocellular carcinoma in high-risk cases: another tool in the toolbox.
    Brown KT
    J Vasc Interv Radiol; 2014 Jul; 25(7):1073-4. PubMed ID: 24968727
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
    Wehrenberg-Klee E; Gandhi RT; Ganguli S
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yttrium-90 radioembolization for the treatment of primary and metastatic liver tumors.
    Sato KT
    Semin Roentgenol; 2011 Apr; 46(2):159-65. PubMed ID: 21338841
    [No Abstract]   [Full Text] [Related]  

  • 19. Invited commentary.
    Salem R
    J Vasc Interv Radiol; 2011 Oct; 22(10):1362-3. PubMed ID: 21961980
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluoroscopic Radiation Exposure in Chemoembolization and Radioembolization: Results from a Prospective Randomized Study.
    Gabr A; Kallini JR; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2017 Sep; 28(9):1272-1273. PubMed ID: 28841927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.